Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
NCT ID: NCT01635959
Last Updated: 2014-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3170 participants
OBSERVATIONAL
2012-07-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevelance and Severity of Gerd in Patients With Metabolic Syndrome and How Both Affect Together ( Relationship)
NCT07302022
Anthropometric Measures and Severity of Gastroesophageal Reflux Disease
NCT01954667
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
NCT01215305
Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)
NCT06457334
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
NCT00914342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Gastrointestinal Trackt Symptoms
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attending the medical office and reporting symptoms suggestive of upper gastrointestinal tract symptoms such as heartburn/regurgitation, abdominal pain, bloating, belching and nausea/vomiting.
Exclusion Criteria
* Patients not able to read and/or understand the GERD-Q questionnaire.
* Patients already included in the study in other participating site.
* Patients taking PPIs or H2blockers in the l
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dina A Ahmed, MD
Role: STUDY_DIRECTOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Al Mansurah, , Egypt
Research Site
Al Menia, , Egypt
Research Site
Alex, , Egypt
Research Site
Asuit, , Egypt
Research Site
Aswān, , Egypt
Research Site
Banhā, , Egypt
Research Site
Cairo, , Egypt
Research Site
Domiaat, , Egypt
Research Site
Hurghada, , Egypt
Research Site
Ismailia, , Egypt
Research Site
Kafr ash Shaykh, , Egypt
Research Site
Kalubia, , Egypt
Research Site
Luxor, , Egypt
Research Site
Mahala, , Egypt
Research Site
Menofia, , Egypt
Research Site
Port-Saeed, , Egypt
Research Site
Qina, , Egypt
Research Site
Sharkiah, , Egypt
Research Site
Sohag, , Egypt
Research Site
Suiz, , Egypt
Research Site
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GEG-XXX-2012/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.